BiotechTube

Caspofungin acetate + Placebo

Phase 2Terminated
3 views this week 0 watching💤 Quiet
Interest: 27/100
27
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Invasive Candidiasis

Conditions

Invasive Candidiasis

Trial Timeline

Dec 1, 2010 → Apr 1, 2012

NCT ID
NCT01045798

About Caspofungin acetate + Placebo

Caspofungin acetate + Placebo is a phase 2 stage product being developed by Merck for Invasive Candidiasis. The current trial status is terminated. This product is registered under clinical trial identifier NCT01045798. Target conditions include Invasive Candidiasis.

What happened to similar drugs?

10 of 20 similar drugs in Invasive Candidiasis were approved

Approved (10) Terminated (2) Active (9)
✅MicafunginAstellas PharmaApproved
✅caspofunginMerckApproved
✅SOC +Posaconazole 18 MG/ML (milligram/milliliter)MerckApproved
✅Caspofungin + Normal SalineMerckApproved
✅Ambisome + caspofunginGilead SciencesApproved
✅13-valent Pneumococcal conjugate vaccinePfizerApproved
✅voriconazolePfizerApproved

Hype Score Breakdown

Clinical
12
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01045798Phase 2Terminated

Competing Products

20 competing products in Invasive Candidiasis

See all competitors
ProductCompanyStageHype Score
BSG005Alkem LaboratoriesPhase 1/2
39
pegylated liposomal doxorubicin (PLD) + PD-1CSPC Pharmaceutical Group LimitedPhase 2
31
Trastuzumab deruxtecan + DurvalumabDaiichi SankyoPhase 2
42
Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
40
Micafungin + fluconazoleAstellas PharmaPhase 3
40
MicafunginAstellas PharmaPre-clinical
26
Micafungin (Mycamine)Astellas PharmaPhase 1
29
Pudexacianinium chlorideAstellas PharmaPhase 2
35
Enfortumab vedotin + PembrolizumabAstellas PharmaPhase 2
42
Enfortumab Vedotin + PembrolizumabAstellas PharmaPhase 2
42
Isavuconazonium sulfate + Voriconazole + PosaconazoleAstellas PharmaPre-clinical
26
Pembrolizumab + Enfortumab VedotinAstellas PharmaPhase 3
44
Isavuconazonium sulfate + Isavuconazonium sulfateAstellas PharmaPhase 2
35
Micafungin + Systemic antifungal therapyAstellas PharmaPhase 2
27
MicafunginAstellas PharmaPre-clinical
26
Micafungin + PlaceboAstellas PharmaPhase 3
32
MicafunginAstellas PharmaApproved
35
Olorofim + AmBisome®ShionogiPhase 3
44
Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel + Epirubicin or doxorubicin, cyclophosphamide, paclitaxelJiangsu Hengrui MedicinePhase 3
44
SHR-A1811 + Trastuzumab EmtansineJiangsu Hengrui MedicinePhase 3
47